semaglutide quiz Quiz: Who Is a Candidate For Semaglutide? – Armando Soto, MD, FACS GLP-1 Quiz

Mehal says it will be at least a year (in the fall of 2026) before it starts landing in patients hands

A cross-sectional study found that low serum levels of IGF-1 are associated with the increase of vertebral fractures among postmenopausal women with type 2 diabetes [1]

X-inactivation profile reveals extensive variability in X-linked gene expression in females

SURMOUNT-5 was a phase 3b randomized controlled trial conducted at 32 sites across the United States and Puerto Rico.[1] A total of 751 adults with obesity but without type 2 diabetes were randomly assigned to receive either tirzepatide or semaglutide once weekly by subcutaneous injection for 72 weeks, which is just under 17 months.[1] Both medications were increased to the maximum tolerated dose

Some practitioners inject directly into target muscle groups (intramuscular), though evidence for localized effect beyond systemic distribution remains anecdotal

The safety profile of GLP-1 RAs in adolescents largely mirrors that observed in adult populations, with gastrointestinal adverse events being the most common concern